Celebrex Related Published Studies
Well-designed clinical trials related to Celebrex (Celecoxib)
Phase II, Randomized, Placebo-Controlled Trial of Neoadjuvant Celecoxib in Men With Clinically Localized Prostate Cancer: Evaluation of Drug-Specific Biomarkers. [2009.10.20]
Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study. [2009.08]
Celecoxib in the Management of Acute Renal Colic: A Randomized Controlled Clinical Trial. [2009.07.08]
Comparing safety and efficacy of first-line irinotecan/fluoropyrimidine combinations in elderly versus nonelderly patients with metastatic colorectal cancer: findings from the bolus, infusional, or capecitabine with camptostar-celecoxib study. [2009.06.15]
Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions. [2009.06.14]
15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors. [2009.06.09]
Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma. [2009.06]
A randomized controlled trial investigating the effects of celecoxib in patients with localized prostate cancer. [2009.05]
Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial. [2009.04]
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. [2009.04]
A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer. [2009.03]
Efficacy of celecoxib on controlling irregular uterine bleeding secondary to Jadelle use. [2009.03]
A randomized, multicentre, double-blind, parallel-group study to assess the adverse event-related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis. [2009.03]
Celecoxib does not appear to affect prosthesis fixation in total knee replacement: A randomized study using radiostereometry in 50 patients. [2009.02]
[Effects of perioperative administration of celecoxib on pain management and recovery of function after total knee replacement] [2009.01.15]
A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis. [2009.01]
Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults. [2008.12]
Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study. [2008.12]
Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled study. [2008.10]
[Postoperative analgesia after laparoscopic cholecystectomy: comparison of the preoperative administration of celecoxib with paracetamol?] [2008.10]
Celecoxib pre-treatment in human colorectal adenocarcinoma patients is associated with gene expression alterations suggestive of diminished cellular proliferation. [2008.08]
Celecoxib-related gastroduodenal ulcer and cardiovascular events in a randomized trial for gastric cancer prevention. [2008.07.28]
Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer. [2008.07]
Perioperative celecoxib administration for pain management after total knee arthroplasty - a randomized, controlled study. [2008.06.03]
Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjects. [2008.06]
Aberrant crypt foci in the adenoma prevention with celecoxib trial. [2008.06]
Cognitive Function Over Time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): Results of a Randomized, Controlled Trial of Naproxen and Celecoxib. [2008.05.12]
Celecoxib is a CYP1A2 inhibitor in vitro but not in vivo. [2008.05]
Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015. [2008.05]
Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis. [2008.04.22]
Pilot randomized phase II study of celecoxib in oral premalignant lesions. [2008.04.01]
A prospective randomized trial on the role of perioperative celecoxib administration for total knee arthroplasty: improving clinical outcomes. [2008.04]
Treatment of advanced hormone-sensitive breast cancer in postmenopausal women with exemestane alone or in combination with celecoxib. [2008.03.10]
Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: a randomised controlled trial in patients with osteoarthritis. [2008.03.07]
Perioperative versus postoperative celecoxib on patient outcomes after major plastic surgery procedures. [2008.03]
Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. [2008.03]
Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study. [2008.03]
Endoscopic ulcer rates in healthy subjects associated with use of aspirin (81 mg q.d.) alone or coadministered with celecoxib or naproxen: a randomized, 1-week trial. [2008.03]
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203. [2008.02.20]
Oral celecoxib versus oral diclofenac for post-perineal repair analgesia after spontaneous vaginal birth: a randomised trial. [2008.02]
The effect of a selective cyclooxygenase-2 inhibitor (celecoxib) on chronic periodontitis. [2008.01]
Lumiracoxib 400 mg compared with celecoxib 400 mg and placebo for treating pain following dental surgery: a randomized, controlled trial. [2008.01]
Results of a pilot study of the effects of celecoxib on cancer cachexia in patients with cancer of the head, neck, and gastrointestinal tract. [2008.01]
Analgesic effectiveness of celecoxib and diclofenac in patients with osteoarthritis of the hip requiring joint replacement surgery: a 12-week, multicenter, randomized, double-blind, parallel-group, double-dummy, noninferiority study. [2008.01]
A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease. [2007.12]
A comparison of the efficacy and safety of celecoxib 200 mg and celecoxib 400 mg once daily in treating the signs and symptoms of psoriatic arthritis. [2007.12]
Lumiracoxib 400 mg Compared With Celecoxib 400 mg and Placebo for Treating Pain Following Dental Surgery: A Randomized, Controlled Trial. [2007.10.13]
Effects of celecoxib on blood loss, pain, and recovery of function after total knee replacement: a randomized placebo-controlled trial. [2007.10]
Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial. [2007.10]
Celecoxib versus magnesium sulfate to arrest preterm labor: randomized trial. [2007.10]
Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial. [2007.09]
Randomised, open label, controlled trial of celecoxib in the treatment of acute migraine. [2007.09]
Effect of celecoxib on restenosis after coronary angioplasty with a Taxus stent (COREA-TAXUS trial): an open-label randomised controlled study. [2007.08.18]
Effects of nimesulide on pain and on synovial fluid concentrations of substance P, interleukin-6 and interleukin-8 in patients with knee osteoarthritis: comparison with celecoxib. [2007.08]
Evaluating the analgesic efficacy of administering celecoxib as a component of multimodal analgesia for outpatient anterior cruciate ligament reconstruction surgery. [2007.07]
Concurrent celecoxib versus placebo in patients with stage II-III non-small cell lung cancer: a randomised phase II trial. [2007.07]
Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. [2007.05.22]
Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial. [2007.05]
Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial. [2007.04.04]
A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain. [2007.03]
Adjusted indirect comparison of celecoxib versus rofecoxib on cardiovascular risk. [2007.03]
Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial. [2007.02]
A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip. [2007.01]
Evaluation of the patient acceptable symptom state in a pooled analysis of two multicentre, randomised, double-blind, placebo-controlled studies evaluating lumiracoxib and celecoxib in patients with osteoarthritis. [2007]
Analgesic efficacy of celecoxib in postoperative oral surgery pain: a single-dose, two-center, randomized, double-blind, active- and placebo-controlled study. [2007]
The analgesic efficacy of celecoxib, pregabalin, and their combination for spinal fusion surgery. [2006.11]
A randomized double-blind placebo-controlled phase II trial of the cyclooxygenase-2 inhibitor Celecoxib in the treatment of cervical dysplasia. [2006.11]
Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen. [2006.10]
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease. [2006.09]
Celecoxib for the prevention of colorectal adenomatous polyps. [2006.08.31]
Celecoxib for the prevention of sporadic colorectal adenomas. [2006.08.31]
Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac. [2006.08]
Celecoxib treatment alters the gene expression profile of normal colonic mucosa. [2006.07]
Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies. [2006.07]
Does celecoxib potentiate the anticoagulant effect of warfarin? A randomized, double-blind, controlled trial. [2006.07]
Trial of celecoxib in amyotrophic lateral sclerosis. [2006.07]
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. [2006.07]
Celecoxib versus placebo for men with prostate cancer and a rising serum prostate-specific antigen after radical prostatectomy and/or radiation therapy. [2006.06.20]
Analgesic efficacy of perioperative celecoxib in ambulatory arthroscopic knee surgery: a double-blind, placebo-controlled study. [2006.06]
Efficacy and tolerability of celecoxib compared with diclofenac slow release in the treatment of acute ankle sprain in an Asian population. [2006.06]
The effects of celecoxib augmentation on cytokine levels in schizophrenia. [2006.06]
Effects of the selective cyclooxygenase-2 inhibitor analgesic celecoxib on renal carbonic anhydrase enzyme activity: a randomized, controlled trial. [2006.05]
Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study. [2006.03]
Indomethacin and celecoxib impair rotator cuff tendon-to-bone healing. [2006.03]
Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study. [2006.02]
First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215]. [2006]
Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. [2005.11]
Pharmacokinetic interactions of the oral renin inhibitor aliskiren with lovastatin, atenolol, celecoxib and cimetidine. [2005.11]
Serum lipid profiles in patients receiving endocrine treatment for breast cancer--the results from the Celecoxib Anti-Aromatase Neoadjuvant (CAAN) Trial. [2005.10]
Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib. [2005.09]
Celecoxib augmentation of continuously ill patients with schizophrenia. [2005.06.15]
Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies. [2005.06]
Effects of indomethacin and celecoxib on renal function in athletes. [2005.05]
Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib. [2005.04]
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. [2005.03.17]
A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10/L-carnitine for the treatment of cocaine dependence. [2005.03]
Celecoxib improves the efficiency of the locomotor mechanism in patients with knee osteoarthritis. A randomised, placebo, double-blind and cross-over trial. [2005.03]
Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites. [2005.03]
Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. [2005.02]
Celecoxib and ketoprofen for pain management during tonsillectomy: a placebo-controlled clinical trial. [2005.02]
Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo. [2005.01]
|
